Our Disclosure

The content on this website includes links to our partners and we may receive compensation when you sign up, at no cost to you. This may impact which products or services we write about and where and how they appear on the site. It does not affect the objectivity of our evaluations or reviews. Read our disclosure.

The Best Pharmaceutical Stocks in Canada for 2024


Fact Checked

Pharmaceuticals are a critical part of our healthcare system. These companies provide vaccines and medications that treat thousands of diseases and medical conditions.

Investing in pharmaceutical stocks is an aggressive and sometimes risky strategy. But when that strategy pays off, it can be extremely lucrative. Here are our choices for Canada’s five best pharmaceutical stocks for 2024.

  1. Knight Therapeutics (GUD.TO)
  2. HLS Therapeutics (HLS.TO)
  3. Cipher Pharmaceuticals (CPH.TO)
  4. Bausch Health Companies (BHC.TO)
  5. Fennec Pharmaceuticals (FRX.TO)

5 Best Pharmaceutical Stocks in Canada

1. Knight Therapeutics Inc.

Here are some key facts about this company:

Ticker SymbolGUD.TO
Market Cap$557.29 million
PE Ratio71.43
52-Week Trading Range$4.28 to $5.50
Dividend YieldN/A

Knight Therapeutics is a Montreal-based company that does not do research and development on new medications and drugs like other pharmaceutical companies. Instead, Knight partners with other pharmaceutical companies and provides investment capital and funding to develop drugs.

Its primary markets are Canada and Latin America, and Knight has offices in 10 different countries across those regions. Knight has a strong portfolio of drugs, including oncology treatments. It already has established partnerships with companies like Bristol Myers Squibb and AstraZeneca.

Buy Stocks & ETFs Free on Wealthsimple Trade ($25 Bonus)

2. HLS Therapeutics Inc.

Here are some key facts about this company:

Ticker SymbolHLS.TO
Market Cap$113.85 million
PE RatioN/A
52-Week Trading Range$3.37 to $11.22
Dividend YieldN/A

HLS Therapeutics is similar to Knight Therapeutics in that it does not manufacture any of the medications that it sells. Instead, it focuses on mergers and acquisitions and analyzes the industry for undervalued companies or treatments.

Two of its best-selling drugs include Vascepa and Clozarilm, the former of which has established a promotional agreement with Pfizer. One potential concern is that the company recently stopped paying out its dividend. The last distribution came on June 15, 2023, and as of now, there is no indication that HLS is bringing it back.

3. Cipher Pharmaceuticals Inc.

Here are some key facts about this company:

Ticker SymbolCPH.TO
Market Cap$149.42 million
PE Ratio15.60
52-Week Trading Range$3.11 to $6.35
Dividend YieldN/A

Yet another Canadian pharmaceutical company that does not produce medications but acquires them for distribution. Cipher focuses mostly on North and South American markets and has a strong product pipeline that fulfills unmet medical needs.

The company’s top product is Epuris, an oral acne treatment. Most of its drugs treat dermatological issues like rashes, acne, and impetigo. Cipher has a relatively strong financial position for being such a small company and is entirely debt-free as of 2023.

4. Bausch Health Companies

Here are some key facts about this company:

Ticker SymbolBHC.TO
Market Cap$3.41 billion
PE Ratio1.75
52-Week Trading Range$7.56 to $13.81
Dividend YieldN/A

Bausch Health Companies is the largest company on this list by market cap. The stock is dual-listed on both the TSX and the NYSE. It also might be the closest thing to a traditional pharmaceutical company because Bausch researches and develops their own pharmaceutical products.

The company manufactures a wide range of generic and branded medications and over-the-counter products. These treatments are sold in more than 90 countries worldwide and treat everything from gastrointestinal problems to dental issues to vision care.

5. Fennec Pharmaceuticals Inc.

Here are some key facts about this company:

Ticker SymbolFRX.TO
Market Cap$321 million
PE Ratio24.57
52-Week Trading Range$9.27 to $14.41
Dividend YieldN/A

Fennec Pharmaceuticals trades on the TSX but is a company headquartered in North Carolina. This company focuses on a single product called PEDMARK, an FDA-approved injection for pediatric patients with non-metastatic solid tumours.

The treatment works to reduce the ototoxicity associated with cisplatin which is a chemotherapy medication. PEDMARK’s orange book patents are protected until at least 2039, providing the company long-term stability over its sole product. Both UK and EU approval for PEDMARK has also been granted in 2023.

How to Buy Pharmaceutical Stocks in Canada

Canadian pharmaceutical stocks are high-risk high-reward investments. If you are interested in buying these stocks, why not save on commission fees with a discount brokerage service like Wealthsimple or Questrade?

Wealthsimple Trade

wealthsimple logo

Trade stocks, ETFs, and options

Excellent trading platform for beginners

Deposit $150+ to get a $25 cash bonus

Transfer fees waived up to $150


questrade logo

Trade stocks, ETFs, options, FX, bonds, CFDs, mutual funds, etc.

Get $50 trade credit with $1,000 funding

Low and competitive trading fees

No quarterly inactivity fees

Access to advanced tools and trading data

Top platform for advanced traders

Transfer fees waived

Pharmaceutical Stocks Explained

Pharmaceutical stocks are companies that research, develop, manufacture, and distribute medical treatments. These can include drugs, medications, and vaccines.

There is a wide range of companies in the pharmaceutical sector. They range from blue-chip companies like Johnson & Johnson to early-stage companies still seeking regulatory approval.

How to Choose Pharma Stocks in Canada

For the most part, Canadian pharma companies are small, especially compared to the large American pharma firms. Choosing stocks requires researching their existing products and pipeline of potential drugs in the future.

Other factors you will want to look at include the lifespan of current patents and the company’s history with obtaining regulatory approvals. As always, looking at fundamentals like the company’s balance sheet and current and forward-looking financial position doesn’t hurt.

Are Pharma and Biotech Stocks Good Investments?

They can be but are also considered some of the riskier investments you can make. Small-cap biotech and pharma stocks have been some of the largest gains and you only need to be right on a few of them to make the sector worth investing in.

On the other end of the spectrum, blue-chip pharma stocks can be incredibly stable. Some of the biggest blue-chip companies in the world are pharma stocks that also have a long history of paying out and increasing their dividends.

Downsides of Pharmaceutical Stocks

Pharma stocks can be incredibly risky. They have as much of a chance of going to zero as they do tripling in price. If anything impacts a pharma company’s products or pipeline, the stock can take a massive hit.

Often, when a company does not achieve regulatory approval, you will see a major decline in the stock’s price. Failure or rejection of just one product can seriously alter a pharma stock’s investment thesis and by the time it happens, it is often too late.

Are there Pharmaceutical ETFs

The closest thing to a pharmaceutical ETF that trades on the TSX is probably the iShares Global Healthcare Index ETF (CAD-Hedged) (XHC.TO). This fund holds some of the world’s largest blue-chip pharma stocks, like Eli Lilly, AbbVie, and Johnson & Johnson.

A few US-listed pharmaceutical ETFs include:


Choosing pharma stocks has a lot to do with your personal risk tolerance. If you are seeking safety and stable dividends then consider some of the blue-chip big pharma companies.

But if you want to hit the potential home run, then you can consider the early-stage biotech companies.

As we mentioned, some of the most important aspects of pharma stocks to consider are the current portfolio of drugs, the pipeline of up-and-coming drugs, and the lifetime of those patents.


DIY Investing Course for Beginners: Grow Your Wealth Like a Pro

Want to become a do-it-yourself investor, save on investment fees, grow your wealth, and reach financial independence? Enroll in this online investing course to learn the exact steps you need to take to get started. Time to make your money work for you!

Investing Course for Beginners Featured Image

Step-by-step video instructions on how to trade stocks and ETFs on multiple brokerage platforms

30+ on-demand videos and presentations covering must-know investment concepts

Guides, workbooks, and reference material (20,000+ words)

Learn to assess your risk profile, develop an investment strategy, and build a diversified portfolio

Confidence to navigate the financial markets and stay on track under all financial conditions

24/7 access to all course material and future updates

Exclusive bonuses and access to live webinars

And lots more…


Editorial Disclaimer: The investing information provided here is for informational purposes only and is not intended as individual investment advice or recommendation to invest in any specific security or investment product. Investors should always conduct their own independent research before making investment decisions or executing investment strategies. Savvy New Canadians does not offer advisory or brokerage services. Note that past investment performance does not guarantee future returns.

Top Investment Offers This month

Grow your stock portfolio and get $50 in FREE trading credit

Top discount trading platform in Canada for beginners and seasoned investors.

Get up to a $50 trading fee when you fund your account with $1000.

Zero trading commissions for ETF purchases (save up to $10 per transaction).

Transfer fees are waived up to $150 when you transfer assets from other banks.

Overall best crypto exchange in Canada with a $50 bonus

Get a $50 instant bonus when your initial deposit is at least $250.

Top Canadian crypto exchange with advanced trading tools & multiple fiats.

Buy and sell the most popular cryptocurrencies and earn interest on assets.

Pay some of the lowest trading fees in Canada.


Gravatar for Enoch Omololu, MSc (Econ)
Enoch Omololu, MSc (Econ)

Enoch Omololu, personal finance expert, author, and founder of Savvy New Canadians, has written about money matters for over 10 years. Enoch has an MSc (Econ) degree in Finance and Investment Management from the University of Aberdeen Business School and has completed the Canadian Securities Course. His expertise has been highlighted in major publications like Forbes, Globe and Mail, Business Insider, CBC News, Toronto Star, Financial Post, CTV News, TD Direct Investing, Canadian Securities Exchange, and many others. Enoch is passionate about helping others win with their finances and recently created a practical investing course for beginners. You can read his full author bio.

About Savvy New Canadians

Savvy New Canadians is one of Canada's top personal finance platforms. Millions of Canadians use our site each year to learn how to save for retirement, invest smartly, maximize rewards, and earn extra cash. We have been featured in prominent finance media, including Forbes, Globe and Mail, Business Insider, CBC, MSN, Wealthsimple, and TD Direct Investing. Learn more about Savvy New Canadians.

Free financial education

Expert advice

Free resources

Detailed guides

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Want to become a do-it-yourself investor, grow your wealth, cut investment fees, and reach financial independence? Enroll in this top-rated online investing course to learn the exact steps you need to take to get started, and get a 50% discount today!*
*The 50% discount is a limited-time offer.

Want to become a DIY investor, grow your wealth, cut investment fees, and reach financial independence? Enroll in this top-rated online investing course to learn the exact steps you need to take and get a 50% discount today!*

*The 50% discount is a limited-time offer.
Thank you for joining the waitlist for our investing course! Check your email for the confirmation message.
Thank you for joining the waitlist for our investing course! Check your email for the confirmation message.